BioPharma Clinical Trials
FDA Approves Donanemab for Early Alzheimer's: C2N Diagnostics' Biomarkers Play Crucial Role in Landmark Study
C2N Diagnostics, a leader in advanced brain health diagnostics, is closely tracking today’s decision by the U.S. Food and Drug Administration to appr...
July 03, 2024 | News
South Korea's PharmAbcine Advances Novel nAMD Treatment PMC-403 to Key Phase 1 Milestones
PharmAbcine, a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today the decision to advance ...
July 02, 2024 | News
HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries
Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...
July 02, 2024 | News
Alteogen Subsidiary Altos Biologics Submits MAA to EMA for ALT-L9 Aflibercept Biosimilar
Alteogen Inc. announced that its subsidiary, Altos Biologics Inc. has submitted Marketing Authorization Application (MAA) to the European Medicines Ag...
July 02, 2024 | News
Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability
Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...
July 01, 2024 | News
Harbour BioMed Resubmits BLA for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis
Harbour BioMed , a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing ...
June 27, 2024 | News
Huadong Medicine Announces Positive Phase I Clinical Trial Results for Oral GLP-1 Receptor Agonist HDM1002 in China
HUADONG MEDICINE, through its wholly-owned subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO. LTD (Zhongmei HuaDong), has recently announced positive ...
June 27, 2024 | News
South Korea Approves Reimbursement for Antengene's XPOVIO®, Expanding Access to Relapsed/Refractory Multiple Myeloma Treatment
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treat...
June 27, 2024 | News
Merck Halts Phase III TrilynX Study for Xevinapant in Head and Neck Cancer Following Interim Analysis
Merck, a leading science and technology company, announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant plus chemora...
June 25, 2024 | News
FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment
U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...
June 25, 2024 | News
EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer
— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...
June 24, 2024 | News
Novo Nordisk's FRONTIER2 Trial: Up to 95% of cPatients Achieve Zero Bleeds on Mim8
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had no prior prophylaxis treatment, experienced zero treated bleeds while on Mim...
June 24, 2024 | News
Gilead Sciences Announces 100% Efficacy in Phase 3 PURPOSE 1 Trial for HIV Prevention in Cisgender Women
Gilead Sciences, Inc. announced topline results from an interim analysis of its pivotal Phase 3 PURPOSE 1 trial, demonstrating that the company’s twi...
June 21, 2024 | News
Enveda Biosciences Secures $55 Million in Latest Financing Round
Enveda Biosciences a biotechnology company using AI to translate nature into new medicines, announced today a new financing round of $55 million to add to ...
June 17, 2024 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
